According to the Legislative Budget Board (LBB), SB 1822 would have no significant fiscal implication to the State of Texas. The Texas Department of Insurance, the primary state agency affected by the bill, is expected to absorb any administrative costs associated with reviewing and processing the newly required annual artificial intelligence compliance statements using existing resources and personnel.

Additionally, the bill does not impose any fiscal impact on local governments. Since the proposed regulations apply specifically to private health insurance issuers and health maintenance organizations (HMOs) and do not mandate new duties for counties, cities, or other local entities, there are no anticipated expenditures or operational burdens at the local level.

This assessment suggests that SB 1822 is fiscally neutral for both state and local governments, making it an administratively feasible policy option without requiring new appropriations or funding streams. The focus remains on regulatory compliance by private insurers rather than creating new government programs or enforcement bodies.

The legislation seeks to address rising concerns about the use of artificial intelligence (AI) in healthcare decision-making—particularly in utilization review processes—by enhancing transparency and oversight. The author points to evidence of biased algorithmic decision-making, which has led to inappropriate denials of medical claims, disproportionately affecting vulnerable populations. The bill is positioned as a safeguard against such misuse, aiming to ensure that AI tools are used responsibly and in line with clinical best practices.

While the bill analysis supports the underlying goals of fairness, transparency, and patient protection, it also reveals the bill’s broader implications for regulation and private enterprise. The Committee Substitute notably shifts the compliance mechanism from direct submission of proprietary algorithms to the Texas Department of Insurance to a more balanced approach via compliance statements, thus protecting intellectual property while maintaining oversight. This modification directly responds to concerns about overregulation, showing a legislative intent to avoid unnecessary intrusion into business operations.

Despite these improvements, the bill still imposes annual reporting obligations and grants the insurance commissioner broad authority to inspect AI systems upon suspicion of noncompliance. This could have chilling effects on innovation or impose significant administrative burdens, especially on smaller insurers. From a liberty perspective, the legislation promotes individual liberty and consumer protection but may unnecessarily infringe upon free enterprise and limited government principles unless further narrowed in scope.

Therefore, Texas Policy Research recommends that lawmakers vote NO on SB 1822 unless amended as described below. To better align with liberty principles, lawmakers should consider limiting regulatory discretion, ensuring protection for proprietary information, and providing alternative compliance options (e.g., third-party audits). These adjustments would maintain the bill's core intent while better balancing innovation, patient rights, and government restraint.

• Individual Liberty: The bill enhances individual liberty by requiring health insurers and HMOs to disclose their use of AI in utilization reviews. This empowers patients, providers, and the public with information about how medical decisions are being made—especially those that could affect access to care. Transparency ensures that individuals are not unknowingly subjected to automated decisions without recourse or awareness. Additionally, by mandating that algorithms minimize bias and follow clinical guidelines, the bill safeguards against discriminatory practices that could infringe on fair treatment in healthcare.
• Personal Responsibility: The legislation has a neutral impact on personal responsibility. It neither incentivizes nor discourages individuals from managing their own healthcare decisions, but it does ensure that they are not unfairly denied care due to opaque or biased AI processes. It provides the conditions for more informed decision-making but does not directly promote or hinder the principle of individual accountability.
• Free Enterprise: The bill raises concerns in terms of free enterprise. By imposing new compliance and disclosure requirements—especially the detailed annual AI compliance statements and oversight powers—it introduces administrative costs and potential legal risks for insurers. Although the substitute version softens the burden by no longer requiring direct algorithm submission (unless noncompliance is suspected), the bill still increases regulatory friction. Smaller or emerging insurers may be disproportionately impacted, potentially hindering innovation in health technology and AI-driven efficiencies.
• Private Property Rights: There is no direct seizure or regulation of physical property, but the bill implicates intellectual property rights by requiring detailed descriptions of AI models and training data and allowing the commissioner to demand algorithm access under certain conditions. While the substitute bill limits disclosure to summaries unless warranted, the possibility of compelled access could be seen as an intrusion on proprietary technologies. This creates potential tension with the principle of protecting private property.
• Limited Government: The bill expands the regulatory authority of the Texas Department of Insurance by introducing new compliance mandates and enforcement discretion. The commissioner is authorized to request additional documentation or inspect AI systems if noncompliance is suspected. While this oversight is aimed at preventing harm, it introduces a level of discretionary government intervention that may challenge the principle of limited government. The scope of the authority is broad and could benefit from clearer checks or thresholds for action.